JetBlue Airways remains unprofitable, with slow progress on its JetForward plan and ongoing operating losses. See why I rate ...
Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback